Acuis Daily is written by AI based on official sources. It may contain errors or omissions. Acuis Daily is for information purposes only. It is not legal or professional advice. Always check the official source before relying on an entry.
6 Nov 2026
/
Commission
/
Implementing rule
Commission drafts amendment to Mirataz veterinary medicine authorisation
The draft implementing decision would amend the marketing authorisation for the veterinary medicinal product Mirataz (mirtazapine), granted by Decision C(2019) 9085 final.
Importance
Routine
Lenses
Regulatory
Why it matters
This is a routine draft amendment to the authorisation of a single veterinary medicine.
Institutions
CommissionStanding Committee on veterinary medicinal products
Audience
Regulatory affairs teams
Tags
Health
Sectors
Pharmaceuticals
References
- Commission decision: C(2019) 9085
- Comitology meeting: CMTD(2026)1920